Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Study completedNCT02358161
What this trial is testing

Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 78
Testing effectiveness (Phase 2)Looking for participantsNCT06584227
What this trial is testing

Adebrelimab and Chidamide for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Liu Xiufeng 45
Not applicableStudy completedNCT04603586
What this trial is testing

Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses

Who this might be right for
Treatment
Changhai Hospital 119
Early research (Phase 1)Study completedNCT02155088
What this trial is testing

BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Early research (Phase 1)Study completedNCT01188785
What this trial is testing

Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Silenseed Ltd 15
Not applicableLooking for participantsNCT06698458
What this trial is testing

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaMetastatic Pancreatic Cancer
Alpha Tau Medical LTD. 50
Testing effectiveness (Phase 2)Ended earlyNCT01834235
What this trial is testing

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Precision Biologics, Inc 81
Testing effectiveness (Phase 2)Study completedNCT04247165
What this trial is testing

Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.

Who this might be right for
Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
Herlev Hospital 55
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Testing effectiveness (Phase 2)Study completedNCT03807999
What this trial is testing

Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer

Who this might be right for
Pancreatic Neoplasm
Hacettepe University 125
Early research (Phase 1)Temporarily pausedNCT07173374
What this trial is testing

Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic Cancer
Shandong Cancer Hospital and Institute 24
Testing effectiveness (Phase 2)Study completedNCT02210559
What this trial is testing

Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer (Unresectable)
Kyntra Bio 37
Testing effectiveness (Phase 2)Looking for participantsNCT06405490
What this trial is testing

NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC

Who this might be right for
Nanoliposomal IrinotecanCadonilimabOxaliplatin+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Early research (Phase 1)Study completedNCT00001431
What this trial is testing

A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas

Who this might be right for
Gastrointestinal NeoplasmsPancreatic Neoplasms
National Cancer Institute (NCI) 20
Not applicableUnknownNCT06539806
What this trial is testing

Clinical Study Evaluating the Effect of Losartan

Who this might be right for
Pancreatic Cancer
Tanta University 90
Large-scale testing (Phase 3)UnknownNCT00075452
What this trial is testing

Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT02810418
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors

Who this might be right for
NeoplasmsPancreatic Neoplasms
National Cancer Institute (NCI) 40
Not applicableUnknownNCT04548960
What this trial is testing

OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients

Who this might be right for
CANCER
Oncodesign SA 600
Testing effectiveness (Phase 2)UnknownNCT06153368
What this trial is testing

Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC

Who this might be right for
Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Next Page